Ischemic cardiomyopathy results from the combination of scar with fibrosis replacement and
areas of dysfunctional but viable myocardium that may improve contractile function with …

In clinical decision making, myocardial viability is defined as myocardium in acute or chronic
coronary artery disease and other conditions with contractile dysfunction but maintained …

Patients with ischaemic left ventricular dysfunction frequently undergo myocardial viability
testing. The historical model presumes that those who have extensive areas of dysfunctional …

Ischaemic heart disease (IHD) continues to be the most common cause of death globally
according to WHO and is the most common cause of heart failure in the developed world. 1 …

Background—Whether viability imaging can impact long-term patient outcomes is uncertain.
The PARR-2 study (Positron Emission Tomography and Recovery Following …

Ischaemic cardiomyopathy (ICM) represents an important cardiovascular condition
associated with substantially increased morbidity and mortality. It is characterised from a …

Despite major advances, ischemic cardiomyopathy (ICM) remains a significant cause of
death and disability worldwide, with coronary artery disease (CAD) the leading cause of left …

Myocardial viability assessment is typically reserved for patients with coronary artery
disease and significant left ventricular dysfunction. In this setting, there is myocardial …

Although major advances have occurred lately in medical therapy, ischemic heart failure
remains an important cause of death and disability. Viable myocardium represents a cause …

Myocardial responses to acute ischemia/reperfusion and to chronic ischemic conditions
have been studied extensively at all levels of organization. These include subcellular (eg …